GUERBET (GBT.PA) Stock Price & Overview
EPA:GBT • FR0000032526
The current stock price of GBT.PA is 12.26 EUR. Today GBT.PA is down by -1.61%. In the past month the price decreased by -9.85%. In the past year, price decreased by -54.59%.
GBT.PA Key Statistics
- Market Cap
- 154.966M
- P/E
- 20.43
- Fwd P/E
- 86.70
- EPS (TTM)
- 0.60
- Dividend Yield
- 2.69%
GBT.PA Stock Performance
GBT.PA Stock Chart
GBT.PA Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to GBT.PA. When comparing the yearly performance of all stocks, GBT.PA is a bad performer in the overall market: 94.97% of all stocks are doing better.
GBT.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to GBT.PA. Both the profitability and financial health of GBT.PA have multiple concerns.
GBT.PA Earnings
GBT.PA Forecast & Estimates
10 analysts have analysed GBT.PA and the average price target is 13.82 EUR. This implies a price increase of 12.73% is expected in the next year compared to the current price of 12.26.
For the next year, analysts expect an EPS growth of -96.34% and a revenue growth -6.62% for GBT.PA
GBT.PA Groups
Sector & Classification
GBT.PA Financial Highlights
Over the last trailing twelve months GBT.PA reported a non-GAAP Earnings per Share(EPS) of 0.6. The EPS decreased by -77.27% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 0.96% | ||
| ROA | 0.76% | ||
| ROE | 2.06% | ||
| Debt/Equity | 0.93 |
GBT.PA Ownership
GBT.PA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ESL | ESSILORLUXOTTICA | 26.43 | 100.395B | ||
| 1EL | ESSILORLUXOTTICA | 26.45 | 100.071B | ||
| EL | ESSILORLUXOTTICA | 26.47 | 100.024B | ||
| CVX | CARVOLIX SA | N/A | 131.822M | ||
| ALCJ | CROSSJECT | 5.73 | 107.896M | ||
| PTP | PENTIXAPHARM HOLDING AG | N/A | 51.584M |
Related stock screener links
View all stocks in the Health Care Supplies Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Paris Exchange | Find stocks with similar TA and Setup ratings on the EuroNext exchanges | Find stocks with similar Fundamental rating on the EuroNext exchanges | Find the competitors with the best technical ratings on the EuroNext exchanges | Find the competitors with the best fundamentals on the EuroNext exchanges | Find the competitors with the best valuation on the EuroNext exchanges | Find the competitors with the best dividend on the EuroNext exchanges | Find the competitors with the best analyst ratings on the EuroNext exchanges
About GBT.PA
Company Profile
Guerbet SA engages in the research, development, manufacture, and sale of contrast products for medical imaging. The company is headquartered in Villepinte, Ile-De-France. The company produces medical imaging contrast products for x-ray imaging, magnetic resonance imaging (MRI), ultrasound imaging and for nuclear medicine. The contrast agents are used in the diagnosis of cardio-vascular, inflammatory and neuro-degenerative disorders. The Company’s portfolio of products comprises brands, such as Xenetix, Hexabrix, Optiray, Oxilan, Telebrix, Lipiodol, Dotarem, Endorem, Artirem, Lumirem, and Lipiodol, among others. Guerbet SA is also active in the fine chemicals industry through its Simafex subsidiary. The firm operates through its subsidiaries, including Simafex, Medex, SCI KALB, Guerbet LLC, Guerbet Asie Pacifique and Guerbet GmbH, among others.
Company Info
GUERBET
15 rue des Vanesses, Zone Paris Nord II
Villepinte ILE-DE-FRANCE FR
Employees: 2842
Phone: 33145915000
GUERBET / GBT.PA FAQ
What does GBT do?
Guerbet SA engages in the research, development, manufacture, and sale of contrast products for medical imaging. The company is headquartered in Villepinte, Ile-De-France. The company produces medical imaging contrast products for x-ray imaging, magnetic resonance imaging (MRI), ultrasound imaging and for nuclear medicine. The contrast agents are used in the diagnosis of cardio-vascular, inflammatory and neuro-degenerative disorders. The Company’s portfolio of products comprises brands, such as Xenetix, Hexabrix, Optiray, Oxilan, Telebrix, Lipiodol, Dotarem, Endorem, Artirem, Lumirem, and Lipiodol, among others. Guerbet SA is also active in the fine chemicals industry through its Simafex subsidiary. The firm operates through its subsidiaries, including Simafex, Medex, SCI KALB, Guerbet LLC, Guerbet Asie Pacifique and Guerbet GmbH, among others.
What is the stock price of GUERBET today?
The current stock price of GBT.PA is 12.26 EUR. The price decreased by -1.61% in the last trading session.
Does GUERBET pay dividends?
GUERBET (GBT.PA) has a dividend yield of 2.69%. The yearly dividend amount is currently 0.5.
How is the ChartMill rating for GUERBET?
GBT.PA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
How is the market expecting GBT stock to perform?
10 analysts have analysed GBT.PA and the average price target is 13.82 EUR. This implies a price increase of 12.73% is expected in the next year compared to the current price of 12.26.
What is the employee count for GBT stock?
GUERBET (GBT.PA) currently has 2842 employees.
Can you provide the upcoming earnings date for GUERBET?
GUERBET (GBT.PA) will report earnings on 2026-03-11.